Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MabPlex International
Yantai, Shandong, Chinamabplex.com ↗
- Ownership
- Private
- Employees
- ~628
- Development stage
- Other
01
Overview
MabPlex provides commercial and clinical manufacturing services for partners; no proprietary clinical trial results, but supports IND-stage and commercial products
- Modalities
- Monoclonal antibodyAntibody-drug conjugateRecombinant proteinBispecific monoclonal antibody
- Industry
- Contract Manufacturing Organization
02
Partnerships
SUMGEN (strategic cooperation for commercial production of SG301 project)Encure Biopharma (collaboration noted for IND submission)
Beyond the preview
Go deeper on MabPlex International.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MabPlex International.